Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Frontiers in Pharmacology
|
October 17, 2022
Aminooxyacetic acid hemihydrochloride inhibits osteoclast differentiation and bone resorption by attenuating oxidative phosphorylation
Biao Yang, Yuangang Su, Shuai Han, et al.
Phytotherapy Research : PTR
|
February 15, 2024
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone loss
Yansi Xian, Yijie Gao, Yiji Su, et al.
Biochemical Pharmacology
|
September 7, 2021
Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
Yansi Xian, Yuangang Su, Jiamin Liang, et al.
Drug Design, Development and Therapy
|
January 14, 2021
Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
Xuedong Li, Xixi Lin, Zuoxing Wu, et al.
Journal of Translational Medicine
|
January 10, 2026
MSDC-0160, a novel clinical-stage mitochondrial pyruvate carrier inhibitor, suppresses osteoclast differentiation and alleviates type 2 diabetes-related bone loss
Chaofeng Wang, Na Hai, Liuyuan Chen, et al.
International Immunopharmacology
|
November 3, 2022
AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis
Shuyue Yang, Dezhi Song, Ziyi Wang, et al.
Journal of Biochemical and Molecular Toxicology
|
March 21, 2022
Corilagin attenuates osteoclastic osteolysis by enhancing HO-1 and inhibiting ROS
Shaolin Tan, Yuangang Su, Linke Huang, et al.
Theranostics
|
December 11, 2024
Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolism
Liuyuan Chen, Yuangang Su, Chaofeng Wang, et al.
Iscience
|
September 18, 2023
CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca<sup>2+</sup> oscillations and NF-κB/MAPK signaling pathways
Minglian Xu, Dezhi Song, Xiaoxiao Xie, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 23, 2025
Brevilin A, a novel BNIP3 inhibitor suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss via impairing mitophagy and mitochondrial metabolism
Rui Zhou, Yiyuan Wang, Siyi Liu, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Frontiers in Pharmacology
|
October 17, 2022
Aminooxyacetic acid hemihydrochloride inhibits osteoclast differentiation and bone resorption by attenuating oxidative phosphorylation
Biao Yang, Yuangang Su, Shuai Han, et al.
Phytotherapy Research : PTR
|
February 15, 2024
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone loss
Yansi Xian, Yijie Gao, Yiji Su, et al.
Biochemical Pharmacology
|
September 7, 2021
Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
Yansi Xian, Yuangang Su, Jiamin Liang, et al.
Drug Design, Development and Therapy
|
January 14, 2021
Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
Xuedong Li, Xixi Lin, Zuoxing Wu, et al.
Journal of Translational Medicine
|
January 10, 2026
MSDC-0160, a novel clinical-stage mitochondrial pyruvate carrier inhibitor, suppresses osteoclast differentiation and alleviates type 2 diabetes-related bone loss
Chaofeng Wang, Na Hai, Liuyuan Chen, et al.
International Immunopharmacology
|
November 3, 2022
AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis
Shuyue Yang, Dezhi Song, Ziyi Wang, et al.
Journal of Biochemical and Molecular Toxicology
|
March 21, 2022
Corilagin attenuates osteoclastic osteolysis by enhancing HO-1 and inhibiting ROS
Shaolin Tan, Yuangang Su, Linke Huang, et al.
Theranostics
|
December 11, 2024
Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolism
Liuyuan Chen, Yuangang Su, Chaofeng Wang, et al.
Iscience
|
September 18, 2023
CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca<sup>2+</sup> oscillations and NF-κB/MAPK signaling pathways
Minglian Xu, Dezhi Song, Xiaoxiao Xie, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 23, 2025
Brevilin A, a novel BNIP3 inhibitor suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss via impairing mitophagy and mitochondrial metabolism
Rui Zhou, Yiyuan Wang, Siyi Liu, et al.
Page
of 5